IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Return on equity 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-56.0%FY2025 · since FY2016: -31.7% → -56.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -56.0% | -3.6 pp |
| FY2024 | -52.4% | +23.6 pp |
| FY2023 | -76.0% | — |
| FY2018 | -26.5% | +36.8 pp |
| FY2017 | -63.3% | -31.6 pp |
| FY2016 | -31.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Gross marginIOVA Operating incomeIOVA Operating marginIOVA Operating cash flowIOVA Free cash flowIOVA Capital expendituresIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Total liabilitiesIOVA Shareholders’ equityIOVA overview →